Caffeine prevents acute mortality after TBI in rats without increased morbidity

被引:39
作者
Lusardi, Theresa A. [1 ]
Lytle, Nikki K. [1 ]
Szybala, Cory [1 ]
Boison, Detlev [1 ]
机构
[1] Legacy Res Inst, Robert Stone Dow Neurobiol Labs, Portland, OR 97232 USA
关键词
FPI; Caffeine; Traumatic brain injury; Apnea; EEG; Neuroprotection; TRAUMATIC BRAIN-INJURY; SUDDEN UNEXPECTED DEATH; FLUID PERCUSSION INJURY; ADENOSINE KINASE; POSTTRAUMATIC EPILEPSY; HEAD-INJURY; RECEPTORS; EPILEPTOGENESIS; OVEREXPRESSION; MODEL;
D O I
10.1016/j.expneurol.2011.12.026
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Severe traumatic brain injury (TBI) is associated with a high incidence of acute mortality followed by chronic alteration of homeostatic network activity that includes the emergence of posttraumatic seizures. We hypothesized that acute and chronic outcome after severe TBI critically depends on disrupted bioenergetic network homeostasis, which is governed by the availability of the brain's endogenous neuroprotectant adenosine. We used a rat lateral fluid percussion injury (FPI) model of severe TBI with an acute mortality rate of 46.7%. A subset of rats was treated with 25 mg/kg caffeine intraperitoneally within 1 min of the injury. We assessed neuromotor function at 24 h and 4 weeks, and video-EEG activity and histology at 4 weeks following injury. We first demonstrate that acute mortality is related to prolonged apnea and that a single acute injection of the adenosine receptor antagonist caffeine can completely prevent TBI-induced mortality when given immediately following the TBI. Second, we demonstrate that neuromotor function is not affected by caffeine treatment at either 24 h or 4 weeks following injury. Third, we demonstrate development of epileptiform EEG bursts as early as 4 weeks post-injury that are significantly reduced in duration in the rats that received caffeine. Our data demonstrate that acute treatment with caffeine can prevent lethal apnea following fluid percussion injury, with no negative influence on motor function or histological outcome. Further, we show epileptiform bursting is reduced after caffeine treatment, suggesting a potential role in the modulation of epilepsy development after severe injury. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:161 / 168
页数:8
相关论文
共 57 条
[1]   Caffeine impairs short-term neurological outcome after concussive head injury in rats [J].
Al Moutaery, K ;
Al Deeb, S ;
Khan, HA ;
Tariq, M .
NEUROSURGERY, 2003, 53 (03) :704-711
[2]  
[Anonymous], 2000, J Neurotrauma, V17, P471, DOI DOI 10.1089/NEU.2000.17.471
[3]   Caffeine consumption [J].
Barone, JJ ;
Roberts, HR .
FOOD AND CHEMICAL TOXICOLOGY, 1996, 34 (01) :119-129
[4]   CARDIORESPIRATORY FUNCTION IS ALTERED BY PICOMOLE INJECTIONS OF 5'-N-ETHYLCARBOXAMIDOADENOSINE INTO THE NUCLEUS TRACTUS SOLITARIUS OF RATS [J].
BARRACO, RA ;
JANUSZ, CA ;
SCHOENER, EP ;
SIMPSON, LL .
BRAIN RESEARCH, 1990, 507 (02) :234-246
[5]   Adenosine and sleep-wake regulation [J].
Basheer, R ;
Strecker, RE ;
Thakkar, MM ;
McCarley, RW .
PROGRESS IN NEUROBIOLOGY, 2004, 73 (06) :379-396
[6]   Interstitial adenosine, inosine, and hypoxanthine are increased after experimental traumatic brain injury in the rat [J].
Bell, MJ ;
Kochanek, PM ;
Carcillo, JA ;
Mi, ZC ;
Schiding, JK ;
Wisniewski, SR ;
Clark, RSB ;
Dixon, CE ;
Marion, DW ;
Jackson, E .
JOURNAL OF NEUROTRAUMA, 1998, 15 (03) :163-170
[7]   Interstitial brain adenosine and xanthine increase during jugular venous oxygen desaturations in humans after traumatic brain injury [J].
Bell, MJ ;
Robertson, CS ;
Kochanek, PM ;
Goodman, JC ;
Gopinath, SP ;
Carcillo, JA ;
Clark, RSB ;
Marion, DW ;
Mi, ZC ;
Jackson, EK .
CRITICAL CARE MEDICINE, 2001, 29 (02) :399-404
[8]   Neonatal hepatic steatosis by disruption of the adenosine kinase gene [J].
Boison, D ;
Scheurer, L ;
Zumsteg, V ;
Rülicke, T ;
Litynski, P ;
Fowler, B ;
Brandner, S ;
Mohler, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (10) :6985-6990
[9]  
Boison D., 2010, Handbookof Experimental Pharmacology, P251, DOI [10.1007/978-3-642-13443-29, DOI 10.1007/978-3-642-13443-29]
[10]  
Boison D., 2011, EXPERT OPIN DRUG DIS, P1